Vesell E S, Passananti G T, Aurori K C
Pharmacology. 1975;13(2):101-11. doi: 10.1159/000136891.
Conflicting results were obtained in three drug interaction experiments designed to determine in man effects of chronic nortriptyline administration on plasma antipyrine half-lives. In an apparently similar design, each experiment utilized normal volunteers whose plasma antipyrine half-lives were measured before and after chronic nortriptyline administration. The same dose of liquid nortriptyline (0.2 mg/kg p.o. t.i.d. for 8 days) was used in each experiment. All subjects in the first study prolonged their plasma antipyrine half-lives, whereas seven of nine subjects in the second study significantly shortened their plasma antipyrine half-lives. In the third experiment seven of nine subjects showed no significant change in plasma antipyrine half-life. An explanation for these conflicting results obtained in the same laboratory under apparently similar experimental conditions was sought in the nature of the volunteers and in subtle changes in such variables as differences in the batches and length of storage of liquid nortriptyline.
在三项旨在确定慢性服用去甲替林对人体血浆安替比林半衰期影响的药物相互作用实验中,得到了相互矛盾的结果。在一项明显相似的设计中,每项实验都使用了正常志愿者,在慢性服用去甲替林之前和之后测量他们的血浆安替比林半衰期。每项实验都使用了相同剂量的液体去甲替林(0.2毫克/千克,口服,每日三次,共8天)。第一项研究中的所有受试者都延长了他们的血浆安替比林半衰期,而第二项研究中的9名受试者中有7名显著缩短了他们的血浆安替比林半衰期。在第三项实验中,9名受试者中有7名的血浆安替比林半衰期没有显著变化。在同一实验室,在明显相似的实验条件下得到这些相互矛盾的结果,原因可能在于志愿者的性质以及诸如液体去甲替林批次差异和储存时间等变量的细微变化。